T cells composition (low CD4:CD8 ratio and reduced population of Tscm, Tcm) in MM patients, along with an enrichment of terminally exhausted T cells, are the main features observed in BCMA targeted CAR-T or BCMA-CD3 BiTEs therapies-resistant patients [65]. Here, CD8A is linked to Miyoshi myopathy.